The influence of metallothionein treatment and treadmill running exercise on disease onset and survival in SOD1 G93A amyotrophic lateral sclerosis mice-Reference-Cited by-同舟云学术

The influence of metallothionein treatment and treadmill running exercise on disease onset and survival in SOD1 G93A amyotrophic lateral sclerosis mice

Published:2020-01-30 Issue:4 Volume:52 Page:3223-3241
ISSN:0953-816X
Container-title:European Journal of Neuroscience
language:en
Short-container-title:Eur J Neurosci

Author:

Lewis Katherine E. A.¹²^ORCID,Bennett William¹²,Blizzard Christopher L.³,West Adrian K.¹²,Chung Roger S.⁴,Chuah Meng Inn¹²

Affiliation:

1. School of Medicine University of Tasmania Hobart TAS Australia

2. Wicking Dementia Research and Education Centre University of Tasmania Hobart TAS Australia

3. Menzies Institute for Medical Research University of Tasmania Hobart TAS Australia

4. Australian School of Advanced Medicine Macquarie University Sydney NSW Australia

Funder

Motor Neurone Disease Research Institute of Australia

Publisher

Wiley

Subject

General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejn.14682

Reference74 articles.

1. Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family

2. The functional significance of brain metallothioneins

3. Peptides modeled after the α-domain of metallothionein induce neurite outgrowth and promote survival of cerebellar granule neurons

4. Intraneuronal signaling pathways of metallothionein

5. Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wheel Running Adversely Affects Disease Onset and Neuromuscular Interplay in Amyotrophic Lateral Sclerosis Slow Progression Mouse Model;Current Neurovascular Research;2023-08

2. Metallothioneins, a Part of the Retinal Endogenous Protective System in Various Ocular Diseases;Antioxidants;2023-06-10